New Developments in the Pathogenesis and Management of Neonatal Pulmonary Hypertension

The Newborn Lung: Neonatology Questions and Controversies

Volumn , Issue , 2008, Pages 241-299

  Aschner, Judy L ^a,b   Fike, Candice D ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b MONROE CARELL JR CHILDREN S HOSPITAL AT VANDERBILT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70349825388     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-141603166-6.10012-9     Document Type: Chapter

References (450)

1. AM Rudolph (1985) Distribution and regulation of blood flow in the fetal and neonatal lamb. Circ Res 57 811
2. AM Rudolph and MA Heymann (1970) Circulatory changes during growth in the fetal lamb. Circ Res 26 289
3. NH Fishman, RB Hof, AM Rudolph, et al. (1978) Models of congenital heart disease in fetal lambs. Circulation 58 354
4. AM Rudolph (1977) Fetal and neonatal pulmonary circulation. Am Rev Respir Dis 115 11
5. PW Soothill, KH Nicolaides, CH Rodeck, et al. (1986) Blood gases and acid-base status of the human second-trimester fetus. Obstet Gynecol 68 173
6. DF Teitel, HS Iwamoto and AM Rudolph (1990) Changes in the pulmonary circulation during birth-related events. Pediatr Res 27 372
7. EE Lawson, RL Birdwell, PS Huang, et al. (1979) Augmentation of pulmonary surfactant secretion by lung expansion at birth. Pediatr Res 13 611
8. WE Truog (1984) Surface active material: influence of lung distension and mechanical ventilation on secretion. Semin Perinatol 8 300
9. RB Haddad Grellins (1977) The role of airway receptors in the control of respiration in infants: a review. J Pediatr 91 281
10. DF Teitel, HS Iwamoto and AM Rudolph (1987) Effects of birth-related events on central blood flow patterns. Pediatr Res 22 557
11. HS Iwamoto, D Teitel and AM Rudolph (1987) Effects of birth-related events on blood flow distribution. Pediatr Res 22 634
12. DL Levin, AM Rudolph, MA Heymann, et al. (1976) Morphological development of the pulmonary vascular bed in fetal lambs. Circulation 53 144
13. AM Rudolph (1970) The changes in the circulation after birth. Their importance in congenital heart disease. Circulation 41 343
14. AM Rudolph (1979) Fetal and neonatal pulmonary circulation. Annu Rev Physiol 41 383
15. JP Kinsella, DD Ivy and SH Abman (1994) Ontogeny of NO activity and response to inhaled NO in the developing ovine pulmonary circulation. Am J Physiol 267 H1955
16. FC Morin III and EA Egan (1992) Pulmonary hemodynamics in fetal lambs during development at normal and increased oxygen tension. J Appl Physiol 73 213
17. RL Naeye (1961) Arterial changes during the perinatal period. Arch Pathol 71 121
18. A Hislop and L Reid (1972) Intra-pulmonary arterial development during fetal life-branching pattern and structure. J Anat 113 35
19. J Belik, A Halayko, K Rao, et al. (1991) Pulmonary vascular smooth muscle: biochemical and mechanical developmental changes. J Appl Physiol 71 1129
20. R Ariel Gomez, BC Sturgill, RL Chevalier, et al. (1987) Fetal expression of muscle-specific isoactins in multiple organs of the Wistar-Kyoto rat. Cell Tissue Res 250 7
21. HJ Colebatch, GS Dawes, JW Goodwin, et al. (1965) The nervous control of the circulation in the foetal and newly expanded lungs of the lamb. J Physiol 178 544
22. AB Lewis, MA Heymann and AM Rudolph (1976) Gestational changes in pulmonary vascular responses in fetal lambs in utero. Circ Res 39 536
23. AM Walker, BC Ritchie, TM Adamson, et al. (1988) Effect of changing lung liquid volume on the pulmonary circulation of fetal lambs. J Appl Physiol 64 61
24. GS Dawes, JC Mott, JG Widdicombe, et al. (1953) Changes in the lungs of the new-born lamb. J Physiol 121 141
25. SH Abman and FJ Accurso (1989) Acute effects of partial compression of ductus arteriosus on fetal pulmonary circulation. Am J Physiol 257 H626
26. FJ Accurso, B Alpert, RB Wilkening, et al. (1986) Time-dependent response of fetal pulmonary blood flow to an increase in fetal oxygen tension. Respir Physiol 63 43
27. L Storme, RL Rairigh, TA Parker, et al. (1999) In vivo evidence for a myogenic response in the fetal pulmonary circulation. Pediatr Res 45 425
28. TA Parker, TR Grover, JP Kinsella, et al. (2005) Inhibition of 20-HETE abolishes the myogenic response during NOS antagonism in the ovine fetal pulmonary circulation. Am J Physiol Lung Cell Mol Physiol 289 L261
29. MJ Davis and MA Hill (1999) Signaling mechanisms underlying the vascular myogenic response. Physiol Rev 79 387
30. J Belik (1994) Myogenic response in large pulmonary arteries and its ontogenesis. Pediatr Res 36 34
31. TJ Kulik, JN Evans and WJ Gamble (1988) Stretch-induced contraction in pulmonary arteries. Am J Physiol 255 H1391
32. TC Lloyd Jr (1986) Pulmonary arterial distension does not cause pulmonary vasoconstriction. J Appl Physiol 61 741
33. FJ Accurso and RB Wilkening (1988) Temporal response of the fetal pulmonary circulation to pharmacologic vasodilators. Proc Soc Exp Biol Med 187 89
34. FC Morin III, EA Egan, W Ferguson, et al. (1988) Development of pulmonary vascular response to oxygen. Am J Physiol 254 H542
35. ML Tod and S Cassin (1984) Perinatal pulmonary responses to arachidonic acid during normoxia and hypoxia. J Appl Physiol 57 977
36. T Tyler, R Wallis, C Leffler, et al. (1975) The effects of indomethacin on the pulmonary vascular response to hypoxia in the premature and mature newborn goat. Proc Soc Exp Biol Med 150 695
37. TL Tyler, CW Leffler and S Cassin (1978) Circulatory responses of perinatal goats to prostaglandin precursors. Prostaglandins Med 1 213
38. ML Tod and S Cassin (1985) Thromboxane synthase inhibition and perinatal pulmonary response to arachidonic acid. J Appl Physiol 58 710
39. M Clozel, RI Clyman, SJ Soifer, et al. (1985) Thromboxane is not responsible for the high pulmonary vascular resistance in fetal lambs. Pediatr Res 19 1254
40. J Lebidois, SJ Soifer, RI Clyman, et al. (1987) Piriprost: a putative leukotriene synthesis inhibitor increases pulmonary blood flow in fetal lambs. Pediatr Res 22 350
41. SJ Soifer, RD Loitz, C Roman, et al. (1985) Leukotriene end organ antagonists increase pulmonary blood flow in fetal lambs. Am J Physiol 249 H570
42. S Cassin (1987) Role of prostaglandins, thromboxanes, and leukotrienes in the control of the pulmonary circulation in the fetus and newborn. Semin Perinatol 11 53
43. SH Abman and KR Stenmark (1992) Changes in lung eicosanoid content during normal and abnormal transition in perinatal lambs. Am J Physiol 262 L214
44. DR Harder, WB Campbell and RJ Roman (1995) Role of cytochrome P-450 enzymes and metabolites of arachidonic acid in the control of vascular tone. J Vasc Res 32 79
45. M Fuloria, TK Smith and JL Aschner (2002) Role of 5,6-epoxyeicosatrienoic acid in the regulation of newborn piglet pulmonary vascular tone. Am J Physiol Lung Cell Mol Physiol 283 L383
46. M Fuloria, DM Eckman, DA Leach, et al. (2004) 20-hydroxyeicosatetraenoic acid is a vasoconstrictor in the newborn piglet pulmonary microcirculation. Am J Physiol Lung Cell Mol Physiol 287 L360
47. JD Morrow and LJ Roberts (2002) The isoprostanes: their role as an index of oxidant stress status in human pulmonary disease. Am J Respir Crit Care Med 166 S25
48. J Belik, RP Jankov, J Pan, et al. (2003) Effect of 8-isoprostaglandin F2alpha on the newborn rat pulmonary arterial muscle and endothelium. J Appl Physiol 95 1979
49. G Gonzalez-Luis, F Perez-Vizcaino, F Garcia-Munoz, et al. (2005) Age-related differences in vasoconstrictor responses to isoprostanes in piglet pulmonary and mesenteric vascular smooth muscle. Pediatr Res 57 845
50. JR Michael and BA Markewitz (1996) Endothelins and the lung. Am J Respir Crit Care Med 154 555
51. C Docherty and MR MacLean (1998) Development of endothelin receptors in perinatal rabbit pulmonary resistance arteries. Br J Pharmacol 124 1165
52. H Toga, BO Ibe and JU Raj (1992) In vitro responses of ovine intrapulmonary arteries and veins to endothelin-1. Am J Physiol 263 L15
53. Y Wang and F Coceani (1992) Isolated pulmonary resistance vessels from fetal lambs. Contractile behavior and responses to indomethacin and endothelin-1. Circ Res 71 320
54. S Cassin, V Kristova, T Davis, et al. (1991) Tone-dependent responses to endothelin in the isolated perfused fetal sheep pulmonary circulation in situ. J Appl Physiol 70 1228
55. BA Chatfield, IF McMurtry, SL Hall, et al. (1991) Hemodynamic effects of endothelin-1 on ovine fetal pulmonary circulation. Am J Physiol 261 R182
56. P D'Orleans-Juste, J Labonte, G Bkaily, et al. (2002) Function of the endothelin(B) receptor in cardiovascular physiology and pathophysiology. Pharmacol Ther 95 221
57. DD Ivy, JP Kinsella and SH Abman (1994) Physiologic characterization of endothelin A and B receptor activity in the ovine fetal pulmonary circulation. J Clin Invest 93 2141
58. ML Tod and S Cassin (1992) Endothelin-1-induced pulmonary arterial dilatation is reduced by N omega-nitro- L-arginine in fetal lambs. J Appl Physiol 72 1730
59. DD Ivy, JP Kinsella and SH Abman (1996) Endothelin blockade augments pulmonary vasodilatation in the ovine fetus. J Appl Physiol 81 2481
60. OW Jones III and SH Abman (1994) Systemic and pulmonary hemodynamic effects of big endothelin-1 and phosphoramidon in the ovine fetus. Am J Physiol 266 R929
61. J Wong, JR Fineman and MA Heymann (1994) The role of endothelin and endothelin receptor subtypes in regulation of fetal pulmonary vascular tone. Pediatr Res 35 664
62. DD Ivy, TD Le Cras, TA Parker, et al. (2000) Developmental changes in endothelin expression and activity in the ovine fetal lung. Am J Physiol Lung Cell Mol Physiol 278 L785
63. TA Parker, G Roe, TR Grover, et al. (2006) Rho kinase activation maintains high pulmonary vascular resistance in the ovine fetal lung. Am J Physiol Lung Cell Mol Physiol 291 L976
64. IF McMurtry, NR Bauer, KA Fagan, et al. (2003) Hypoxia and Rho/Rho-kinase signaling. Lung development versus hypoxic pulmonary hypertension. Adv Exp Med Biol 543 127
65. MP Printz, RA Skidgel and WF Friedman (1984) Studies of pulmonary prostaglandin biosynthetic and catabolic enzymes as factors in ductus arteriosus patency and closure. Evidence for a shift in products with gestational age. Pediatr Res 18 19
66. CR Pace-Asciak (1977) Prostaglandin biosynthesis and catabolism in the developing fetal sheep lung. Prostaglandins 13 649
67. S Cassin (1980) Role of prostaglandins and thromboxanes in the control of the pulmonary circulation in the fetus and newborn. Semin Perinatol 4 101
68. S Cassin, I Winikor, M Tod, et al. (1981) Effects of prostacyclin on the fetal pulmonary circulation. Pediatr Pharmacol (New York) 1 197
69. CW Leffler and JR Hessler (1979) Pulmonary and systemic vascular effects of exogenous prostaglandin I2 in fetal lambs. Eur J Pharmacol 54 37
70. CW Leffler and JR Hessler (1981) Perinatal pulmonary prostaglandin production. Am J Physiol 241 H756
71. CW Leffler, TL Tyler and S Cassin (1978) Effect of indomethacin on pulmonary vascular response to ventilation of fetal goats. Am J Physiol 234 H346
72. AJ North, RA Star, TS Brannon, et al. (1994) Nitric oxide synthase type I and type III gene expression are developmentally regulated in rat lung. Am J Physiol 266 L635
73. AC Halbower, RM Tuder, WA Franklin, et al. (1994) Maturation-related changes in endothelial nitric oxide synthase immunolocalization in developing ovine lung. Am J Physiol 267 L585
74. FI Arrigoni, AA Hislop, JS Pollock, et al. (2002) Birth upregulates nitric oxide synthase activity in the porcine lung. Life Sci 70 1609
75. PW Shaul, S Afshar, LL Gibson, et al. (2002) Developmental changes in nitric oxide synthase isoform expression and nitric oxide production in fetal baboon lung. Am J Physiol Lung Cell Mol Physiol 283 L1192
76. M Levy, C Maurey, B Chailley-Heu, et al. (2005) Developmental changes in endothelial vasoactive and angiogenic growth factors in the human perinatal lung. Pediatr Res 57 248
77. TA Parker, TD Le Cras, JP Kinsella, et al. (2000) Developmental changes in endothelial nitric oxide synthase expression and activity in ovine fetal lung. Am J Physiol Lung Cell Mol Physiol 278 L202
78. RL Rairigh, L Storme, TA Parker, et al. (2000) Role of neuronal nitric oxide synthase in regulation of vascular and ductus arteriosus tone in the ovine fetus. Am J Physiol Lung Cell Mol Physiol 278 L105
79. SH Abman, BA Chatfield, SL Hall, et al. (1990) Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birth. Am J Physiol 259 H1921
80. JW Skimming, VG DeMarco and S Cassin (1995) The effects of nitric oxide inhalation on the pulmonary circulation of preterm lambs. Pediatr Res 37 35
81. LS Shekerdemian, HB Ravn and DJ Penny (2002) Intravenous sildenafil lowers pulmonary vascular resistance in a model of neonatal pulmonary hypertension. Am J Respir Crit Care Med 165 1098
82. J Weimann, R Ullrich, J Hromi, et al. (2000) Sildenafil is a pulmonary vasodilator in awake lambs with acute pulmonary hypertension. Anesthesiology 92 1702
83. RC Dukarm, FC Morin III, JA Russell, et al. (1998) Pulmonary and systemic effects of the phosphodiesterase inhibitor dipyridamole in newborn lambs with persistent pulmonary hypertension. Pediatr Res 44 831
84. B Thebaud, C Saizou, C Farnoux, et al. (1999) Dypiridamole, a cGMP phosphodiesterase inhibitor, transiently improves the response to inhaled nitric oxide in two newborns with congenital diaphragmatic hernia. Intensive Care Med 25 300
85. KA Hanson, JW Ziegler, SD Rybalkin, et al. (1998) Chronic pulmonary hypertension increases fetal lung cGMP phosphodiesterase activity. Am J Physiol 275 L931
86. B Thebaud, T Petit, P De Lagausie, et al. (2002) Altered guanylyl-cyclase activity in vitro of pulmonary arteries from fetal lambs with congenital diaphragmatic hernia. Am J Respir Cell Mol Biol 27 42
87. RH Steinhorn, JB Gordon and ML Tod (2000) Site-specific effect of guanosine 3′,5′-cyclic monophosphate phosphodiesterase inhibition in isolated lamb lungs. Crit Care Med 28 490
88. KG Thusu, FC Morin III, JA Russell, et al. (1995) The cGMP phosphodiesterase inhibitor zaprinast enhances the effect of nitric oxide. Am J Respir Crit Care Med 152 1605
89. S Cassin, GS Dawes, JC Mott, et al. (1964) The vascular resistance of the foetal and newly ventilated lung of the lamb. J Physiol 171 61
90. HS Iwamoto, DF Teitel and AM Rudolph (1993) Effects of lung distension and spontaneous fetal breathing on hemodynamics in sheep. Pediatr Res 33 639
91. DL Reid and KL Thornburg (1990) Pulmonary pressure-flow relationships in the fetal lamb during in utero ventilation. J Appl Physiol 69 1630
92. K Allen and SG Haworth (1988) Human postnatal pulmonary arterial remodeling. Ultrastructural studies of smooth muscle cell and connective tissue maturation. Lab Invest 59 702
93. SG Haworth, SM Hall, M Chew, et al. (1987) Thinning of fetal pulmonary arterial wall and postnatal remodelling: ultrastructural studies on the respiratory unit arteries of the pig. Virchows Arch A Pathol Anat Histopathol 411 161
94. SH Abman (1999) Abnormal vasoreactivity in the pathophysiology of persistent pulmonary hypertension of the newborn. Pediatr Rev 20 e103
95. DA Kelly, AA Hislop, SM Hall, et al. (2002) Correlation of pulmonary arterial smooth muscle structure and reactivity during adaptation to extrauterine life. J Vasc Res 39 30
96. C Hammerman and EM Scarpelli (1984) Indomethacin and the cardiopulmonary adaptations of transition. Pediatr Res 18 842
97. D Davidson (1988) Pulmonary hemodynamics at birth: effect of acute cyclooxygenase inhibition in lambs. J Appl Physiol 64 1676
98. DN Cornfield, BA Chatfield, JA McQueston, et al. (1992) Effects of birth-related stimuli on L-arginine-dependent pulmonary vasodilation in ovine fetus. Am J Physiol 262 H1474
99. H Velvis, P Moore and MA Heymann (1991) Prostaglandin inhibition prevents the fall in pulmonary vascular resistance as a result of rhythmic distension of the lungs in fetal lambs. Pediatr Res 30 62
100. CW Leffler, JR Hessler and RS Green (1984) Mechanism of stimulation of pulmonary prostacyclin synthesis at birth. Prostaglandins 28 877
101. TS Brannon, AJ North, LB Wells, et al. (1994) Prostacyclin synthesis in ovine pulmonary artery is developmentally regulated by changes in cyclooxygenase-1 gene expression. J Clin Invest 93 2230
102. DL Levin (1980) Effects of inhibition of prostaglandin synthesis on fetal development, oxygenation, and the fetal circulation. Semin Perinatol 4 35
103. FR Witter and JR Niebyl (1986) Inhibition of arachidonic acid metabolism in the perinatal period: pharmacology, clinical application, and potential adverse effects. Semin Perinatol 10 316
104. N Kawai, DB Bloch, G Filippov, et al. (1995) Constitutive endothelial nitric oxide synthase gene expression is regulated during lung development. Am J Physiol 268 L589
105. E Villamor, TD Le Cras, MP Horan, et al. (1997) Chronic intrauterine pulmonary hypertension impairs endothelial nitric oxide synthase in the ovine fetus. Am J Physiol 272 L1013
106. M Sheffield, S Mabry, DW Thibeault, et al. (2006) Pulmonary nitric oxide synthases and nitrotyrosine: findings during lung development and in chronic lung disease of prematurity. Pediatrics 118 1056
107. SH Abman, BA Chatfield, DM Rodman, et al. (1991) Maturational changes in endothelium-derived relaxing factor activity of ovine pulmonary arteries in vitro. Am J Physiol 260 L280
108. PW Shaul, MA Farrar and RR Magness (1993) Pulmonary endothelial nitric oxide production is developmentally regulated in the fetus and newborn. Am J Physiol 265 H1056
109. JR Fineman, J Wong, FC Morin III, et al. (1994) Chronic nitric oxide inhibition in utero produces persistent pulmonary hypertension in newborn lambs. J Clin Invest 93 2675
110. AA Miller, AA Hislop, PJ Vallance, et al. (2005) Deletion of the eNOS gene has a greater impact on the pulmonary circulation of male than female mice. Am J Physiol Lung Cell Mol Physiol 289 L299
111. PW Shaul, IS Yuhanna, Z German, et al. (1997) Pulmonary endothelial NO synthase gene expression is decreased in fetal lambs with pulmonary hypertension. Am J Physiol 272 L1005
112. SM Black, JR Fineman, RH Steinhorn, et al. (1998) Increased endothelial NOS in lambs with increased pulmonary blood flow and pulmonary hypertension. Am J Physiol 275 H1643
113. DD Ivy, TD Le Cras, MP Horan, et al. (1998) Increased lung preproET-1 and decreased ETB-receptor gene expression in fetal pulmonary hypertension. Am J Physiol 274 L535
114. SM Black, JM Bekker, MJ Johengen, et al. (2000) Altered regulation of the ET-1 cascade in lambs with increased pulmonary blood flow and pulmonary hypertension. Pediatr Res 47 97
115. P Kumar, NJ Kazzi and S Shankaran (1996) Plasma immunoreactive endothelin-1 concentrations in infants with persistent pulmonary hypertension of the newborn. Am J Perinatol 13 335
116. AA Rosenberg, J Kennaugh, SL Koppenhafer, et al. (1993) Elevated immunoreactive endothelin-1 levels in newborn infants with persistent pulmonary hypertension. J Pediatr 123 109
117. JW Winters, J Wong, DD Van, et al. (1996) Endothelin receptor blockade does not alter the increase in pulmonary blood flow due to oxygen ventilation in fetal lambs. Pediatr Res 40 152
118. EL Dobyns, JY Wescott, JM Kennaugh, et al. (1994) Eicosanoids decrease with successful extracorporeal membrane oxygenation therapy in neonatal pulmonary hypertension. Am J Respir Crit Care Med 149 873
119. WD Ford, MJ James and JA Walsh (1984) Congenital diaphragmatic hernia: association between pulmonary vascular resistance and plasma thromboxane concentrations. Arch Dis Child 59 143
120. KR Stenmark, SL James, NF Voelkel, et al. (1983) Leukotriene C4 and D4 in neonates with hypoxemia and pulmonary hypertension. N Engl J Med 309 77
121. CD Fike and TN Hansen (1987) Hypoxic vasoconstriction increases with postnatal age in lungs from newborn rabbits. Circ Res 60 297
122. JB Gordon, J Hortop and TS Hakim (1989) Developmental effects of hypoxia and indomethacin on distribution of vascular resistances in lamb lungs. Pediatr Res 26 325
123. JB Owen-Thomas and JT Reeves (1969) Hypoxia and pulmonary arterial pressure in the rabbit. J Physiol 201 665
124. A Rendas, M Branthwaite, S Lennox, et al. (1982) Response of the pulmonary circulation to acute hypoxia in the growing pig. J Appl Physiol 52 811
125. AM Rudolph and S Yuan (1966) Response of the pulmonary vasculature to hypoxia and H+ ion concentration changes. J Clin Invest 45 399
126. RK Lyrene, KA Welch, G Godoy, et al. (1985) Alkalosis attenuates hypoxic pulmonary vasoconstriction in neonatal lambs. Pediatr Res 19 1268
127. FC Morin III (1986) Hyperventilation, alkalosis, prostaglandins, and pulmonary circulation of the newborn. J Appl Physiol 61 2088
128. CD Fike and TN Hansen (1989) The effect of alkalosis on hypoxia-induced pulmonary vasoconstriction in lungs of newborn rabbits. Pediatr Res 25 383
129. IS Farrukh, GH Gurtner, PB Terry, et al. (1989) Effect of pH on pulmonary vascular tone, reactivity, and arachidonate metabolism. J Appl Physiol 67 445
130. JB Gordon, FR Martinez, PA Keller, et al. (1993) Differing effects of acute and prolonged alkalosis on hypoxic pulmonary vasoconstriction. Am Rev Respir Dis 148 1651
131. GJ Redding, RL Gibson, CB Davis, et al. (1988) Effects of respiratory alkalosis on thromboxane-induced pulmonary hypertension in piglets. Pediatr Res 24 558
132. C Hammerman and MJ Aramburo (1991) Effects of hyperventilation on prostacyclin formation and on pulmonary vasodilation after group B beta-hemolytic streptococci-induced pulmonary hypertension. Pediatr Res 29 282
133. MD Schreiber, MA Heymann and SJ Soifer (1986) Increased arterial pH, not decreased PaCO 2, attenuates hypoxia-induced pulmonary vasoconstriction in newborn lambs. Pediatr Res 20 113
134. WM Gersony (1984) Neonatal pulmonary hypertension: pathophysiology, classification, and etiology. Clin Perinatol 11 517
135. RD Bland, KH Albertine, DP Carlton, et al. (2000) Chronic lung injury in preterm lambs: abnormalities of the pulmonary circulation and lung fluid balance. Pediatr Res 48 64
136. N Mulrooney, Z Champion, TJ Moss, et al. (2005) Surfactant and physiologic responses of preterm lambs to continuous positive airway pressure. Am J Respir Crit Care Med 171 488
137. JD Murphy, M Rabinovitch, JD Goldstein, et al. (1981) The structural basis of persistent pulmonary hypertension of the newborn infant. J Pediatr 98 962
138. JD Murphy, GF Vawter and LM Reid (1984) Pulmonary vascular disease in fatal meconium aspiration. J Pediatr 104 758
139. SH Abman, PF Shanley and FJ Accurso (1989) Failure of postnatal adaptation of the pulmonary circulation after chronic intrauterine pulmonary hypertension in fetal lambs. J Clin Invest 83 1849
140. J Belik, FW Keeley, F Baldwin, et al. (1994) Pulmonary hypertension and vascular remodeling in fetal sheep. Am J Physiol 266 H2303
141. LM Wild, PA Nickerson and FC Morin III (1989) Ligating the ductus arteriosus before birth remodels the pulmonary vasculature of the lamb. Pediatr Res 25 251
142. VM Reddy, B Meyrick, J Wong, et al. (1995) In utero placement of aortopulmonary shunts. A model of postnatal pulmonary hypertension with increased pulmonary blood flow in lambs. Circulation 92 606
143. JM Jouannic, R Roussin, AA Hislop, et al. (2003) Systemic arteriovenous fistula leads to pulmonary artery remodeling and abnormal vasoreactivity in the fetal lamb. Am J Physiol Lung Cell Mol Physiol 285 L701
144. K Suzuki, SB Hooper, ML Cock, et al. (2005) Effect of lung hypoplasia on birth-related changes in the pulmonary circulation in sheep. Pediatr Res 57 530
145. DL Levin (1978) Morphologic analysis of the pulmonary vascular bed in congenital left-sided diaphragmatic hernia. J Pediatr 92 805
146. J Belik, AJ Halayko, K Rao, et al. (1993) Fetal ductus arteriosus ligation. Pulmonary vascular smooth muscle biochemical and mechanical changes. Circ Res 72 588
147. DA Kelly, AA Hislop, SM Hall, et al. (2005) Relationship between structural remodeling and reactivity in pulmonary resistance arteries from hypertensive piglets. Pediatr Res 58 525
148. J Belik, R Majumdar, VE Fabris, et al. (1998) Myosin light chain phosphatase and kinase abnormalities in fetal sheep pulmonary hypertension. Pediatr Res 43 57
149. JA McQueston, JP Kinsella, DD Ivy, et al. (1995) Chronic pulmonary hypertension in utero impairs endothelium-dependent vasodilation. Am J Physiol 268 H288
150. VM Reddy, J Wong, JR Liddicoat, et al. (1996) Altered endothelium-dependent responses in lambs with pulmonary hypertension and increased pulmonary blood flow. Am J Physiol 271 H562
151. B Wojciak-Stothard and SG Haworth (2006) Perinatal changes in pulmonary vascular endothelial function. Pharmacol Ther 109 78
152. PJ Boels, J Deutsch, B Gao, et al. (2001) Perinatal development influences mechanisms of bradykinin-induced relaxations in pulmonary resistance and conduit arteries differently. Cardiovasc Res 51 140
153. SM Black, JM Bekker, DM McMullan, et al. (2002) Alterations in nitric oxide production in 8-week-old lambs with increased pulmonary blood flow. Pediatr Res 52 233
154. CD Fike and MR Kaplowitz (1994) Effect of chronic hypoxia on pulmonary vascular pressures in isolated lungs of newborn pigs. J Appl Physiol 77 2853
155. RD Bland, CY Ling, KH Albertine, et al. (2003) Pulmonary vascular dysfunction in preterm lambs with chronic lung disease. Am J Physiol Lung Cell Mol Physiol 285 L76
156. CD Fike, JL Aschner, Y Zhang, et al. (2004) Impaired NO signaling in small pulmonary arteries of chronically hypoxic newborn piglets. Am J Physiol Lung Cell Mol Physiol 286 L1244
157. MC Walsh-Sukys, RE Bauer, DJ Cornell, et al. (1994) Severe respiratory failure in neonates: mortality and morbidity rates and neurodevelopmental outcomes. J Pediatr 125 104
158. DC Angus, WT Linde-Zwirble, G Clermont, et al. (2001) Epidemiology of neonatal respiratory failure in the United States: projections from California and New York. Am J Respir Crit Care Med 164 1154
159. DL Pearson, S Dawling, WF Walsh, et al. (2001) Neonatal pulmonary hypertension–urea-cycle intermediates, nitric oxide production, and carbamoyl-phosphate synthetase function. N Engl J Med 344 1832
160. MC Walsh-Sukys, JE Tyson, LL Wright, et al. (2000) Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes. Pediatrics 105 14
161. WW Fox, MH Gewitz, R Dinwiddie, et al. (1977) Pulmonary hypertension in the perinatal aspiration syndromes. Pediatrics 59 205
162. GG Konduri (2004) New approaches for persistent pulmonary hypertension of newborn. Clin Perinatol 31 591
163. RH Steinhorn and JR Fineman (1999) The pathophysiology of pulmonary hypertension in congenital heart disease. Artif Organs 23 970
164. FE Barr, H Beverley, K VanHook, et al. (2003) Effect of cardiopulmonary bypass on urea cycle intermediates and nitric oxide levels after congenital heart surgery. J Pediatr 142 26
165. MA Alano, E Ngougmna, EM Ostrea Jr., et al. (2001) Analysis of nonsteroidal antiinflammatory drugs in meconium and its relation to persistent pulmonary hypertension of the newborn. Pediatrics 107 519
166. CD Chambers, S Hernandez-Diaz, LJ Van Marter, et al. (2006) Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 354 579
167. V Gournay, C Savagner, G Thiriez, et al. (2002) Pulmonary hypertension after ibuprofen prophylaxis in very preterm infants. Lancet 359 1486
168. S Lakshminrusimha, JA Russell, RH Steinhorn, et al. (2006) Pulmonary arterial contractility in neonatal lambs increases with 100% oxygen resuscitation. Pediatr Res 59 137
169. S Lakshminrusimha, JA Russell, S Wedgwood, et al. (2006) Superoxide dismutase improves oxygenation and reduces oxidation in neonatal pulmonary hypertension. Am J Respir Crit Care Med 174 1370
170. M Vento, M Asensi, J Sastre, et al. (2001) Resuscitation with room air instead of 100% oxygen prevents oxidative stress in moderately asphyxiated term neonates. Pediatrics 107 642
171. PM Mourani, DD Ivy, D Gao, et al. (2004) Pulmonary vascular effects of inhaled nitric oxide and oxygen tension in bronchopulmonary dysplasia. Am J Respir Crit Care Med 170 1006
172. JT Wung, LS James, E Kilchevsky, et al. (1985) Management of infants with severe respiratory failure and persistence of the fetal circulation, without hyperventilation. Pediatrics 76 488
173. GJ Peckham and WW Fox (1978) Physiologic factors affecting pulmonary artery pressure in infants with persistent pulmonary hypertension. J Pediatr 93 1005
174. WH Drummond, GA Gregory, MA Heymann, et al. (1981) The independent effects of hyperventilation, tolazoline, and dopamine on infants with persistent pulmonary hypertension. J Pediatr 98 603
175. MA Heymann (1984) Control of the pulmonary circulation in the perinatal period. J Dev Physiol 6 281
176. JP Morray, AM Lynn and PB Mansfield (1988) Effect of pH and PCO 2 on pulmonary and systemic hemodynamics after surgery in children with congenital heart disease and pulmonary hypertension. J Pediatr 113 474
177. AR Dworetz, FR Moya, B Sabo, et al. (1989) Survival of infants with persistent pulmonary hypertension without extracorporeal membrane oxygenation. Pediatrics 84 1
178. EM Bifano and A Pfannenstiel (1988) Duration of hyperventilation and outcome in infants with persistent pulmonary hypertension. Pediatrics 81 657
179. KD Hendricks-Munoz and JP Walton (1988) Hearing loss in infants with persistent fetal circulation. Pediatrics 81 650
180. DK Stevenson, DS Kasting, RA Darnall Jr., et al. (1979) Refractory hypoxemia associated with neonatal pulmonary disease: the use and limitations of tolazoline. J Pediatr 95 595
181. SK Parida, S Baker, R Kuhn, et al. (1997) Endotracheal tolazoline administration in neonates with persistent pulmonary hypertension. J Perinatol 17 461
182. TJ Wu, RJ Teng and KI Tsou (1995) Persistent pulmonary hypertension of the newborn treated with magnesium sulfate in premature neonates. Pediatrics 96 472
183. B Weinberger, K Weiss, DE Heck, et al. (2001) Pharmacologic therapy of persistent pulmonary hypertension of the newborn. Pharmacol Ther 89 67
184. YK Abu-Osba, O Galal, K Manasra, et al. (1992) Treatment of severe persistent pulmonary hypertension of the newborn with magnesium sulphate. Arch Dis Child 67 31
185. SK Patole and NN Finer (1995) Experimental and clinical effects of magnesium infusion in the treatment of neonatal pulmonary hypertension. Magnes Res 8 373
186. Inhaled nitric oxide and hypoxic respiratory failure in infants with congenital diaphragmatic hernia (1997) The Neonatal Inhaled Nitric Oxide Study Group (NINOS). Pediatrics 99 838
187. Inhaled nitric oxide in term and near-term infants (2000) neurodevelopmental follow-up of the neonatal inhaled nitric oxide study group (NINOS). J Pediatr 136 611
188. RH Clark, TJ Kueser, MW Walker, et al. (2000) Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group. N Engl J Med 342 469
189. DL Wessel, I Adatia, LJ Van Marter, et al. (1997) Improved oxygenation in a randomized trial of inhaled nitric oxide for persistent pulmonary hypertension of the newborn. Pediatrics 100 E7
190. JP Kinsella and SH Abman (1998) Inhaled nitric oxide and high frequency oscillatory ventilation in persistent pulmonary hypertension of the newborn. Eur J Pediatr 157(Suppl 1), S28
191. JD Roberts Jr., JR Fineman, FC Morin III, et al. (1997) Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group. N Engl J Med 336 605
192. ES Barefield, VA Karle, JB Phillips III, et al. (1996) Inhaled nitric oxide in term infants with hypoxemic respiratory failure. J Pediatr 129 279
193. H Christou, LJ Van Marter, DL Wessel, et al. (2000) Inhaled nitric oxide reduces the need for extracorporeal membrane oxygenation in infants with persistent pulmonary hypertension of the newborn. Crit Care Med 28 3722
194. D Davidson, ES Barefield, J Kattwinkel, et al. (1998) Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. The I-NO/PPHN Study Group. Pediatrics 101 325
195. NN Finer and KJ Barrington (2006) Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database Syst Rev CD000399
196. PH Lipkin, D Davidson, L Spivak, et al. (2002) Neurodevelopmental and medical outcomes of persistent pulmonary hypertension in term newborns treated with nitric oxide. J Pediatr 140 306
197. MD Schreiber, K Gin-Mestan, JD Marks, et al. (2003) Inhaled nitric oxide in premature infants with the respiratory distress syndrome. N Engl J Med 349 2099
198. KP Van Meurs, LL Wright, RA Ehrenkranz, et al. (2005) Inhaled nitric oxide for premature infants with severe respiratory failure. N Engl J Med 353 13
199. JP Kinsella, GR Cutter, WF Walsh, et al. (2006) Early inhaled nitric oxide therapy in premature newborns with respiratory failure. N Engl J Med 355 354
200. RA Ballard, WE Truog, A Cnaan, et al. (2006) Inhaled nitric oxide in preterm infants undergoing mechanical ventilation. N Engl J Med 355 343
201. JP Kinsella, TA Parker, DD Ivy, et al. (2003) Noninvasive delivery of inhaled nitric oxide therapy for late pulmonary hypertension in newborn infants with congenital diaphragmatic hernia. J Pediatr 142 397
202. BA Banks, I Seri, H Ischiropoulos, et al. (1999) Changes in oxygenation with inhaled nitric oxide in severe bronchopulmonary dysplasia. Pediatrics 103 610
203. RN Channick, JW Newhart, FW Johnson, et al. (1996) Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension: an ambulatory delivery system and initial clinical tests. Chest 109 1545
204. RW Day, JA Hawkins, EC McGough, et al. (2000) Randomized controlled study of inhaled nitric oxide after operation for congenital heart disease. Ann Thorac Surg 69 1907
205. EL Dobyns, DN Cornfield, NG Anas, et al. (1999) Multicenter randomized controlled trial of the effects of inhaled nitric oxide therapy on gas exchange in children with acute hypoxemic respiratory failure. J Pediatr 134 406
206. JP Kinsella and SH Abman (2005) Inhaled nitric oxide therapy in children. Paediatr Respir Rev 6 190
207. OI Miller, SF Tang, A Keech, et al. (2000) Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised double-blind study. Lancet 356 1464
208. DL Weiner, PL Hibberd, P Betit, et al. (2003) Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease. JAMA 289 1136
209. GG Konduri, A Solimano, GM Sokol, et al. (2004) A randomized trial of early versus standard inhaled nitric oxide therapy in term and near-term newborn infants with hypoxic respiratory failure. Pediatrics 113 559
210. Early compared with delayed inhaled nitric oxide in moderately hypoxaemic neonates with respiratory failure: a randomised controlled trial (1999) The Franco-Belgium Collaborative NO Trial Group. Lancet 354 1066
211. R Rossaint, KJ Falke, F Lopez, et al. (1993) Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 328 399
212. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure (1997) The Neonatal Inhaled Nitric Oxide Study Group. N Engl J Med 336 597
213. JP Kinsella, WE Truog, WF Walsh, et al. (1997) Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn. J Pediatr 131 55
214. HL Karamanoukian, PL Glick, M Zayek, et al. (1994) Inhaled nitric oxide in congenital hypoplasia of the lungs due to diaphragmatic hernia or oligohydramnios. Pediatrics 94 715
215. NN Finer, PC Etches, B Kamstra, et al. (1994) Inhaled nitric oxide in infants referred for extracorporeal membrane oxygenation: dose response. J Pediatr 124 302
216. CG Robbins, JM Davis, TA Merritt, et al. (1995) Combined effects of nitric oxide and hyperoxia on surfactant function and pulmonary inflammation. Am J Physiol 269 L545
217. JS Beckman, TW Beckman, J Chen, et al. (1990) Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87 1620
218. SO Guthrie, WF Walsh, K Auten, et al. (2004) Initial dosing of inhaled nitric oxide in infants with hypoxic respiratory failure. J Perinatol 24 290
219. AP Goldman, RC Tasker, SG Haworth, et al. (1996) Four patterns of response to inhaled nitric oxide for persistent pulmonary hypertension of the newborn. Pediatrics 98 706
220. A Lotze, BR Mitchell, DI Bulas, et al. (1998) Multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failure. Survanta in Term Infants Study Group. J Pediatr 132 40
221. H Aly, R Sahni and JT Wung (1997) Weaning strategy with inhaled nitric oxide treatment in persistent pulmonary hypertension of the newborn. Arch Dis Child Fetal Neonatal Ed 76 F118
222. E Cueto, J Lopez-Herce, A Sanchez, et al. (1997) Life-threatening effects of discontinuing inhaled nitric oxide in children. Acta Paediatr 86 1337
223. D Davidson, ES Barefield, J Kattwinkel, et al. (1999) Safety of withdrawing inhaled nitric oxide therapy in persistent pulmonary hypertension of the newborn. Pediatrics 104 231
224. DD Ivy, JP Kinsella, JW Ziegler, et al. (1998) Dipyridamole attenuates rebound pulmonary hypertension after inhaled nitric oxide withdrawal in postoperative congenital heart disease. J Thorac Cardiovasc Surg 115 875
225. JP Kinsella and SH Abman (1995) Recent developments in the pathophysiology and treatment of persistent pulmonary hypertension of the newborn. J Pediatr 126 853
226. SM Black, RS Heidersbach, DM McMullan, et al. (1999) Inhaled nitric oxide inhibits NOS activity in lambs: potential mechanism for rebound pulmonary hypertension. Am J Physiol 277 H1849
227. GM Buga, JM Griscavage, NE Rogers, et al. (1993) Negative feedback regulation of endothelial cell function by nitric oxide. Circ Res 73 808
228. DM McMullan, JM Bekker, MJ Johengen, et al. (2001) Inhaled nitric oxide-induced rebound pulmonary hypertension: role for endothelin-1. Am J Physiol Heart Circ Physiol 280 H777
229. S Wedgwood, DM McMullan, JM Bekker, et al. (2001) Role for endothelin-1-induced superoxide and peroxynitrite production in rebound pulmonary hypertension associated with inhaled nitric oxide therapy. Circ Res 89 357
230. GM Sokol, NS Fineberg, LL Wright, et al. (2001) Changes in arterial oxygen tension when weaning neonates from inhaled nitric oxide. Pediatr Pulmonol 32 14
231. J Gianetti, S Bevilacqua and CR De (2002) Inhaled nitric oxide: more than a selective pulmonary vasodilator. Eur J Clin Invest 32 628
232. DM Guidot, MJ Repine, BM Hybertson, et al. (1995) Inhaled nitric oxide prevents neutrophil-mediated, oxygen radical-dependent leak in isolated rat lungs. Am J Physiol 269 L2
233. JP Kinsella, TA Parker, H Galan, et al. (1997) Effects of inhaled nitric oxide on pulmonary edema and lung neutrophil accumulation in severe experimental hyaline membrane disease. Pediatr Res 41 457
234. LJ Williams, TH Shaffer and JS Greenspan (2004) Inhaled nitric oxide therapy in the near-term or term neonate with hypoxic respiratory failure. Neonatal Netw 23 5
235. SH Abman, RR Wolfe, FJ Accurso, et al. (1985) Pulmonary vascular response to oxygen in infants with severe bronchopulmonary dysplasia. Pediatrics 75 80
236. American Academy of Pediatrics. Committee on Fetus and Newborn (2000) Use of inhaled nitric oxide. Pediatrics 106 344
237. M Ellington Jr., D O'Reilly, EN Allred, et al. (2001) Child health status, neurodevelopmental outcome, and parental satisfaction in a randomized, controlled trial of nitric oxide for persistent pulmonary hypertension of the newborn. Pediatrics 107 1351
238. AA Rosenberg, JM Kennaugh, SG Moreland, et al. (1997) Longitudinal follow-up of a cohort of newborn infants treated with inhaled nitric oxide for persistent pulmonary hypertension. J Pediatr 131 70
239. AA Rosenberg (2002) Outcome in term infants treated with inhaled nitric oxide. J Pediatr 140 284
240. M Hallman and K Kankaanpaa (1980) Evidence of surfactant deficiency in persistence of the fetal circulation. Eur J Pediatr 134 129
241. A Lotze, JA Whitsett, LA Kammerman, et al. (1990) Surfactant protein A concentrations in tracheal aspirate fluid from infants requiring extracorporeal membrane oxygenation. J Pediatr 116 435
242. RL Auten, RH Notter, JW Kendig, et al. (1991) Surfactant treatment of full-term newborns with respiratory failure. Pediatrics 87 101
243. A Lotze, GR Knight, GR Martin, et al. (1993) Improved pulmonary outcome after exogenous surfactant therapy for respiratory failure in term infants requiring extracorporeal membrane oxygenation. J Pediatr 122 261
244. MP Moya, AJ Gow, RM Califf, et al. (2002) Inhaled ethyl nitrite gas for persistent pulmonary hypertension of the newborn. Lancet 360 141
245. TL Fink, SH Francis, A Beasley, et al. (1999) Expression of an active, monomeric catalytic domain of the cGMP-binding cGMP-specific phosphodiesterase (PDE5). J Biol Chem 274 34613
246. J Wharton, JW Strange, GM Moller, et al. (2005) Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells. Am J Respir Crit Care Med 172 105
247. SM Black, LS Sanchez, E Mata-Greenwood, et al. (2001) sGC and PDE5 are elevated in lambs with increased pulmonary blood flow and pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 281 L1051
248. C Buysse, C Fonteyne, H Dessy, et al. (2001) The use of dipyridamole to wean from inhaled nitric oxide in congenital diaphragmatic hernia. J Pediatr Surg 36 1864
249. JP Kinsella, F Torielli, JW Ziegler, et al. (1995) Dipyridamole augmentation of response to nitric oxide. Lancet 346 647
250. KM Binns-Loveman, MR Kaplowitz and CD Fike (2005) Sildenafil and an early stage of chronic hypoxia-induced pulmonary hypertension in newborn piglets. Pediatr Pulmonol 40 72
251. BK Sastry, C Narasimhan, NK Reddy, et al. (2004) Clinical efficacy of sildenafil in primary pulmonary hypertension: a randomized, placebo-controlled, double-blind, crossover study. J Am Coll Cardiol 43 1149
252. E Michelakis, W Tymchak, D Lien, et al. (2002) Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide. Circulation 105 2398
253. JJ Lepore, A Maroo, NL Pereira, et al. (2002) Effect of sildenafil on the acute pulmonary vasodilator response to inhaled nitric oxide in adults with primary pulmonary hypertension. Am J Cardiol 90 677
254. HA Ghofrani, R Wiedemann, F Rose, et al. (2002) Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial. Lancet 360 895
255. N Galie, HA Ghofrani, A Torbicki, et al. (2005) Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 353 2148
256. AM Atz and DL Wessel (1999) Sildenafil ameliorates effects of inhaled nitric oxide withdrawal. Anesthesiology 91 307
257. AE Juliana and FC Abbad (2005) Severe persistent pulmonary hypertension of the newborn in a setting where limited resources exclude the use of inhaled nitric oxide: successful treatment with sildenafil. Eur J Pediatr 164 626
258. H Baquero, A Soliz, F Neira, et al. (2006) Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: a pilot randomized blinded study. Pediatrics 117 1077
259. JN Travadi and SK Patole (2003) Phosphodiesterase inhibitors for persistent pulmonary hypertension of the newborn: a review. Pediatr Pulmonol 36 529
260. CS Marsh, B Marden and R Newsom (2004) Severe retinopathy of prematurity (ROP) in a premature baby treated with sildenafil acetate (Viagra) for pulmonary hypertension. Br J Ophthalmol 88 306
261. CM Pierce, AJ Petros and AR Fielder (2005) No evidence for severe retinopathy of prematurity following sildenafil. Br J Ophthalmol 89 250
262. WC Van Staveren, HW Steinbusch, IM Markerink-Van, et al. (2003) mRNA expression patterns of the cGMP-hydrolyzing phosphodiesterases types 2, 5, and 9 during development of the rat brain. J Comp Neurol 467 566
263. L Zhang, RL Zhang, Y Wang, et al. (2005) Functional recovery in aged and young rats after embolic stroke: treatment with a phosphodiesterase type 5 inhibitor. Stroke 36 847
264. P Namachivayam, U Theilen, WW Butt, et al. (2006) Sildenafil prevents rebound pulmonary hypertension after withdrawal of nitric oxide in children. Am J Respir Crit Care Med 174 1042
265. DG Harrison (1997) Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest 100 2153
266. Y Mitani, K Maruyama and M Sakurai (1997) Prolonged administration of L-arginine ameliorates chronic pulmonary hypertension and pulmonary vascular remodeling in rats. Circulation 96 689
267. CD Fike, MR Kaplowitz, LA Rehorst-Paea, et al. (2000) L-Arginine increases nitric oxide production in isolated lungs of chronically hypoxic newborn pigs. J Appl Physiol 88 1797
268. S Mehta, DJ Stewart, D Langleben, et al. (1995) Short-term pulmonary vasodilatation with L-arginine in pulmonary hypertension. Circulation 92 1539
269. N Nagaya, M Uematsu, H Oya, et al. (2001) Short-term oral administration of L-arginine improves hemodynamics and exercise capacity in patients with precapillary pulmonary hypertension. Am J Respir Crit Care Med 163 887
270. I Schulze-Neick, DJ Penny, ML Rigby, et al. (1999) L-arginine and substance P reverse the pulmonary endothelial dysfunction caused by congenital heart surgery. Circulation 100 749
271. MJ McCaffrey, CL Bose, PD Reiter, et al. (1995) Effect of L-arginine infusion on infants with persistent pulmonary hypertension of the newborn. Biol Neonate 67 240
272. CR Morris, SM Morris Jr, W Hagar, et al. (2003) Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease? Am J Respir Crit Care Med 168 63
273. M Gorenflo, C Zheng, E Werle, et al. (2001) Plasma levels of asymmetrical dimethyl- L-arginine in patients with congenital heart disease and pulmonary hypertension. J Cardiovasc Pharmacol 37 489
274. P Bulau, D Zakrzewicz, K Kitowska, et al. (2007) Analysis of methylarginine metabolism in the cardiovascular system identifies the lung as a major source of ADMA. Am J Physiol Lung Cell Mol Physiol 292 L18
275. RA Dweik (2007) The lung in the balance: arginine, methylated arginines, and nitric oxide. Am J Physiol Lung Cell Mol Physiol 292 L15
276. NC Raiha and J Suihkonen (1968) Factors influencing the development of urea-synthesizing enzymes in rat liver. Biochem J 107 793
277. NC Raiha and J Suihkonen (1968) Development of urea-synthesizing enzymes in human liver. Acta Paediatr Scand 57 121
278. BM Mukarram Ali, CM Habibullah, M Swamy, et al. (1992) Studies on urea cycle enzyme levels in the human fetal liver at different gestational ages. Pediatr Res 31 143
279. DL Pearson, S Dawling, WF Walsh, et al. (2001) Neonatal pulmonary hypertension–urea-cycle intermediates, nitric oxide production, and carbamoyl-phosphate synthetase function. N Engl J Med 344 1832
280. M Summar (2001) Current strategies for the management of neonatal urea cycle disorders. J Pediatr 138 S30
281. KP Kuhn, PA Harris, GR Cunningham, et al. (2002) Oral citrulline effectively elevates plasma arginine levels for 24 hours in normal volunteers. Circulation 106 II-339
282. WJ Hartman, PM Torre and RL Prior (1994) Dietary citrulline but not ornithine counteracts dietary arginine deficiency in rats by increasing splanchnic release of citrulline. J Nutr 124 1950
283. ML Batshaw, S Brusilow, L Waber, et al. (1982) Treatment of inborn errors of urea synthesis: activation of alternative pathways of waste nitrogen synthesis and excretion. N Engl J Med 306 1387
284. ML Batshaw, RC Wachtel, GH Thomas, et al. (1984) Arginine-responsive asymptomatic hyperammonemia in the premature infant. J Pediatr 105 86
285. HA Smith, JA Canter, KG Christian, et al. (2006) Nitric oxide precursors and congenital heart surgery: a randomized controlled trial of oral citrulline. J Thorac Cardiovasc Surg 132 58
286. JL Cracowski, C Cracowski, G Bessard, et al. (2001) Increased lipid peroxidation in patients with pulmonary hypertension. Am J Respir Crit Care Med 164 1038
287. LA Brennan, RH Steinhorn, S Wedgwood, et al. (2003) Increased superoxide generation is associated with pulmonary hypertension in fetal lambs: a role for NADPH oxidase. Circ Res 92 683
288. E Mata-Greenwood, C Jenkins, KN Farrow, et al. (2006) eNOS function is developmentally regulated: uncoupling of eNOS occurs postnatally. Am J Physiol Lung Cell Mol Physiol 290 L232
289. GG Konduri, J Ou, Y Shi, et al. (2003) Decreased association of HSP90 impairs endothelial nitric oxide synthase in fetal lambs with persistent pulmonary hypertension. Am J Physiol Heart Circ Physiol 285 H204
290. GG Konduri, I Bakhutashvili, A Eis, et al. (2007) Oxidant stress from uncoupled nitric oxide synthase impairs vasodilatation in fetal lambs with persistent pulmonary hypertension. Am J Physiol Heart Circ Physiol 292 H1812
291. FM Faraci and SP Didion (2004) Vascular protection: superoxide dismutase isoforms in the vessel wall. Arterioscler Thromb Vasc Biol 24 1367
292. J Belik, RP Jankov, J Pan, et al. (2004) Peroxynitrite inhibits relaxation and induces pulmonary artery muscle contraction in the newborn rat. Free Radic Biol Med 37 1384
293. DW Sheehan, EC Giese, SF Gugino, et al. (1993) Characterization and mechanisms of H 2O 2-induced contractions of pulmonary arteries. Am J Physiol 264 H1542
294. LJ Janssen (2001) Isoprostanes: an overview and putative roles in pulmonary pathophysiology. Am J Physiol Lung Cell Mol Physiol 280 L1067
295. J Belik, RP Jankov, J Pan, et al. (2004) Chronic O 2 exposure in the newborn rat results in decreased pulmonary arterial nitric oxide release and altered smooth muscle response to isoprostane. J Appl Physiol 96 725
296. O Aikio, K Vuopala, ML Pokela, et al. (2003) Nitrotyrosine and NO synthases in infants with respiratory failure: influence of inhaled NO. Pediatr Pulmonol 35 8
297. S Goil, WE Truog, C Barnes, et al. (1998) Eight-epi-PGF2alpha: a possible marker of lipid peroxidation in term infants with severe pulmonary disease. J Pediatr 132 349
298. S Wedgwood and SM Black (2003) Role of reactive oxygen species in vascular remodeling associated with pulmonary hypertension. Antioxid Redox Signal 5 759
299. RH Steinhorn, G Albert, DD Swartz, et al. (2001) Recombinant human superoxide dismutase enhances the effect of inhaled nitric oxide in persistent pulmonary hypertension. Am J Respir Crit Care Med 164 834
300. E Villamor, F Perez-Vizcaino, AL Cogolludo, et al. (2000) Relaxant effects of carbon monoxide compared with nitric oxide in pulmonary and systemic vessels of newborn piglets. Pediatr Res 48 546
301. E Villamor, F Perez-Vizcaino, AL Cogolludo, et al. (2000) Relaxant effects of carbon monoxide compared with nitric oxide in pulmonary and systemic vessels of newborn piglets. Pediatr Res 48 546
302. JP Kinsella, TA Parker, JM Davis, et al. (2005) Superoxide dismutase improves gas exchange and pulmonary hemodynamics in premature lambs. Am J Respir Crit Care Med 172 745
303. JM Davis, WN Rosenfeld, SE Richter, et al. (1997) Safety and pharmacokinetics of multiple doses of recombinant human CuZn superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndrome. Pediatrics 100 24
304. JM Davis, RB Parad, T Michele, et al. (2003) Pulmonary outcome at 1 year corrected age in premature infants treated at birth with recombinant human CuZn superoxide dismutase. Pediatrics 111 469
305. CD Fike, MR Kaplowitz and SL Pfister (2003) Arachidonic acid metabolites and an early stage of pulmonary hypertension in chronically hypoxic newborn pigs. Am J Physiol Lung Cell Mol Physiol 284 L316
306. N Galie, A Manes and A Branzi (2001) Medical therapy of pulmonary hypertension. The prostacyclins. Clin Chest Med 22 529
307. A Widlitz and RJ Barst (2003) Pulmonary arterial hypertension in children. Eur Respir J 21 155
308. M Max and R Rossaint (1999) Inhaled prostacyclin in the treatment of pulmonary hypertension. Eur J Pediatr 158(Suppl 1), S23
309. LK Kelly, NF Porta, DM Goodman, et al. (2002) Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide. J Pediatr 141 830
310. BW Christman, CD McPherson, JH Newman, et al. (1992) An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med 327 70
311. CD Fike, Y Zhang and MR Kaplowitz (2005) Thromboxane inhibition reduces an early stage of chronic hypoxia-induced pulmonary hypertension in piglets. J Appl Physiol 99 670
312. D Langleben, BW Christman, RJ Barst, et al. (2002) Effects of the thromboxane synthetase inhibitor and receptor antagonist terbogrel in patients with primary pulmonary hypertension. Am Heart J 143 E4
313. M Kataoka, N Nagaya, T Satoh, et al. (2005) A long-acting prostacyclin agonist with thromboxane inhibitory activity for pulmonary hypertension. Am J Respir Crit Care Med 172 1575
314. RN Channick, G Simonneau, O Sitbon, et al. (2001) Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study. Lancet 358 1119
315. DB Badesch, F Bodin, RN Channick, et al. (2002) Complete results of the first randomized placebo-controlled study of bosentan, a dual endothelin receptor antagonist, in pulmonary arterial hypertension. Curr Ther Res 63 227
316. LJ Rubin, DB Badesch, RJ Barst, et al. (2002) Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 346 896
317. RJ Barst, D Ivy, J Dingemanse, et al. (2003) Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension. Clin Pharmacol Ther 73 372
318. DD Ivy, A Doran, L Claussen, et al. (2004) Weaning and discontinuation of epoprostenol in children with idiopathic pulmonary arterial hypertension receiving concomitant bosentan. Am J Cardiol 93 943
319. N Gilbert, YC Luther, O Miera, et al. (2005) Initial experience with bosentan (Tracleer) as treatment for pulmonary arterial hypertension (PAH) due to congenital heart disease in infants and young children. Z Kardiol 94 570
320. S Rugolotto, G Errico, R Beghini, et al. (2006) Weaning of epoprostenol in a small infant receiving concomitant bosentan for severe pulmonary arterial hypertension secondary to bronchopulmonary dysplasia. Minerva Pediatr 58 491
321. RJ Barst, D Langleben, D Badesch, et al. (2006) Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan. J Am Coll Cardiol 47 2049
322. HA Ghofrani, F Rose, RT Schermuly, et al. (2003) Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension. J Am Coll Cardiol 42 158
323. M Humbert, RJ Barst, IM Robbins, et al. (2004) Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2. Eur Respir J 24 353
324. SC Mathai, RE Girgis, MR Fisher, et al. (2007) Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertension. Eur Respir J 29 469
325. M Hoeper, H Leuchte, M Halank, et al. (2006) Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension. Eur J Pediatr 28(4), 691
326. MM Hoeper, I Markevych, E Spiekerkoetter, et al. (2005) Goal-oriented treatment and combination therapy for pulmonary arterial hypertension. Eur Respir J 26 858
327. LJ Rubin (2002) Therapy of pulmonary hypertension: the evolution from vasodilators to antiproliferative agents. Am J Respir Crit Care Med 166 1308
328. M Rabinovitch (1998) Elastase and the pathobiology of unexplained pulmonary hypertension. Chest 114 213S
329. KR Stenmark and RP Mecham (1997) Cellular and molecular mechanisms of pulmonary vascular remodeling. Annu Rev Physiol 59 89
330. GH Gibbons and VJ Dzau (1994) The emerging concept of vascular remodeling. N Engl J Med 330 1431
331. NF Voelkel and RM Tuder (1997) Cellular and molecular biology of vascular smooth muscle cells in pulmonary hypertension. Pulm Pharmacol Ther 10 231
332. S Archer and S Rich (2000) Primary pulmonary hypertension: a vascular biology and translational research “Work in progress.”. Circulation 102 2781
333. KR Stenmark, KA Fagan and MG Frid (2006) Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms. Circ Res 99 675
334. L Todorovich-Hunter, DJ Johnson, P Ranger, et al. (1988) Altered elastin and collagen synthesis associated with progressive pulmonary hypertension induced by monocrotaline. A biochemical and ultrastructural study. Lab Invest 58 184
335. IW Prosser, KR Stenmark, M Suthar, et al. (1989) Regional heterogeneity of elastin and collagen gene expression in intralobar arteries in response to hypoxic pulmonary hypertension as demonstrated by in situ hybridization. Am J Pathol 135 1073
336. PL Jones and M Rabinovitch (1996) Tenascin-C is induced with progressive pulmonary vascular disease in rats and is functionally related to increased smooth muscle cell proliferation. Circ Res 79 1131
337. PL Jones, KN Cowan and M Rabinovitch (1997) Tenascin-C, proliferation and subendothelial fibronectin in progressive pulmonary vascular disease. Am J Pathol 150 1349
338. HL Reeve, E Michelakis, DP Nelson, et al. (2001) Alterations in a redox oxygen sensing mechanism in chronic hypoxia. J Appl Physiol 90 2249
339. XJ Yuan, J Wang, M Juhaszova, et al. (1998) Attenuated K+ channel gene transcription in primary pulmonary hypertension. Lancet 351 726
340. MS McMurtry, SL Archer, DC Altieri, et al. (2005) Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension. J Clin Invest 115 1479
341. C Guignabert, B Raffestin, R Benferhat, et al. (2005) Serotonin transporter inhibition prevents and reverses monocrotaline-induced pulmonary hypertension in rats. Circulation 111 2812
342. KN Cowan, WC Leung, C Mar, et al. (2005) Caspases from apoptotic myocytes degrade extracellular matrix: a novel remodeling paradigm. FASEB J 19 1848
343. BH Strauss and M Rabinovitch (2000) Adventitial fibroblasts: defining a role in vessel wall remodeling. Am J Respir Cell Mol Biol 22 1
344. S Bonnet, ED Michelakis, CJ Porter, et al. (2006) An abnormal mitochondrial-hypoxia inducible factor-1alpha-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: similarities to human pulmonary arterial hypertension. Circulation 113 2630
345. KN Cowan, A Heilbut, T Humpl, et al. (2000) Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor. Nat Med 6 698
346. MJ Pollman, T Yamada, M Horiuchi, et al. (1996) Vasoactive substances regulate vascular smooth muscle cell apoptosis. Countervailing influences of nitric oxide and angiotensin II. Circ Res 79 748
347. M Cattaruzza, C Dimigen, H Ehrenreich, et al. (2000) Stretch-induced endothelin B receptor-mediated apoptosis in vascular smooth muscle cells. FASEB J 14 991
348. K Irani (2000) Oxidant signaling in vascular cell growth, death, and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ Res 87 179
349. PL Jones, J Crack and M Rabinovitch (1997) Regulation of tenascin-C, a vascular smooth muscle cell survival factor that interacts with the alpha v beta 3 integrin to promote epidermal growth factor receptor phosphorylation and growth. J Cell Biol 139 279
350. CL Ye and M Rabinovitch (1991) Inhibition of elastolysis by SC-37698 reduces development and progression of monocrotaline pulmonary hypertension. Am J Physiol 261 H1255
351. SH Zaidi, XM You, S Ciura, et al. (2002) Overexpression of the serine elastase inhibitor elafin protects transgenic mice from hypoxic pulmonary hypertension. Circulation 105 516
352. K Maruyama, CL Ye, M Woo, et al. (1991) Chronic hypoxic pulmonary hypertension in rats and increased elastolytic activity. Am J Physiol 261 H1716
353. KN Cowan, PL Jones and M Rabinovitch (2000) Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease. J Clin Invest 105 21
354. SL Merklinger, PL Jones, EC Martinez, et al. (2005) Epidermal growth factor receptor blockade mediates smooth muscle cell apoptosis and improves survival in rats with pulmonary hypertension. Circulation 112 423
355. XJ Yuan, WF Goldman, ML Tod, et al. (1993) Hypoxia reduces potassium currents in cultured rat pulmonary but not mesenteric arterial myocytes. Am J Physiol 264 L116
356. JM Post, JR Hume, SL Archer, et al. (1992) Direct role for potassium channel inhibition in hypoxic pulmonary vasoconstriction. Am J Physiol 262 C882
357. R Moudgil, ED Michelakis and SL Archer (2006) The role of k+ channels in determining pulmonary vascular tone, oxygen sensing, cell proliferation, and apoptosis: implications in hypoxic pulmonary vasoconstriction and pulmonary arterial hypertension. Microcirculation 13 615
358. EK Weir, J Lopez-Barneo, KJ Buckler, et al. (2005) Acute oxygen-sensing mechanisms. N Engl J Med 353 2042
359. XJ Yuan, J Wang, M Juhaszova, et al. (1998) Molecular basis and function of voltage-gated K+ channels in pulmonary arterial smooth muscle cells. Am J Physiol 274 L621
360. ED Michelakis, V Hampl, A Nsair, et al. (2002) Diversity in mitochondrial function explains differences in vascular oxygen sensing. Circ Res 90 1307
361. HL Reeve, EK Weir, DP Nelson, et al. (1995) Opposing effects of oxidants and antioxidants on K+ channel activity and tone in rat vascular tissue. Exp Physiol 80 825
362. K Hasunuma, DM Rodman and IF McMurtry (1991) Effects of K+ channel blockers on vascular tone in the perfused rat lung. Am Rev Respir Dis 144 884
363. TP Robertson, JP Ward and PI Aaronson (2001) Hypoxia induces the release of a pulmonary-selective, Ca(2+)-sensitising, vasoconstrictor from the perfused rat lung. Cardiovasc Res 50 145
364. SL Archer, DP Nelson and EK Weir (1989) Simultaneous measurement of O 2 radicals and pulmonary vascular reactivity in rat lung. J Appl Physiol 67 1903
365. SL Archer, HL Reeve, E Michelakis, et al. (1999) O 2 sensing is preserved in mice lacking the gp91 phox subunit of NADPH oxidase. Proc Natl Acad Sci USA 96 7944
366. A Paky, JR Michael, TM Burke-Wolin, et al. (1993) Endogenous production of superoxide by rabbit lungs: effects of hypoxia or metabolic inhibitors. J Appl Physiol 74 2868
367. JQ Liu, JS Sham, LA Shimoda, et al. (2003) Hypoxic constriction and reactive oxygen species in porcine distal pulmonary arteries. Am J Physiol Lung Cell Mol Physiol 285 L322
368. GB Waypa, NS Chandel and PT Schumacker (2001) Model for hypoxic pulmonary vasoconstriction involving mitochondrial oxygen sensing. Circ Res 88 1259
369. SL Archer, J Huang, T Henry, et al. (1993) A redox-based O 2 sensor in rat pulmonary vasculature. Circ Res 73 1100
370. RD Jones, JS Thompson and AH Morice (2000) The NADPH oxidase inhibitors iodonium diphenyl and cadmium sulphate inhibit hypoxic pulmonary vasoconstriction in isolated rat pulmonary arteries. Physiol Res 49 587
371. KM Mohazzab, RP Fayngersh, PM Kaminski, et al. (1995) Potential role of NADH oxidoreductase-derived reactive O 2 species in calf pulmonary arterial PO 2-elicited responses. Am J Physiol 269 L637
372. KM Mohazzab and MS Wolin (1994) Properties of a superoxide anion-generating microsomal NADH oxidoreductase, a potential pulmonary artery PO 2 sensor. Am J Physiol 267 L823
373. N Weissmann, A Tadic, J Hanze, et al. (2000) Hypoxic vasoconstriction in intact lungs: a role for NADPH oxidase-derived H(2)O(2)? Am J Physiol Lung Cell Mol Physiol 279 L683
374. SL Archer, XC Wu, B Thebaud, et al. (2004) Preferential expression and function of voltage-gated, O 2-sensitive K+ channels in resistance pulmonary arteries explains regional heterogeneity in hypoxic pulmonary vasoconstriction: ionic diversity in smooth muscle cells. Circ Res 95 308
375. ZI Pozeg, ED Michelakis, MS McMurtry, et al. (2003) In vivo gene transfer of the O 2-sensitive potassium channel Kv1.5 reduces pulmonary hypertension and restores hypoxic pulmonary vasoconstriction in chronically hypoxic rats. Circulation 107 2037
376. SL Archer, B London, V Hampl, et al. (2001) Impairment of hypoxic pulmonary vasoconstriction in mice lacking the voltage-gated potassium channel Kv1.5. FASEB J 15 1801
377. SL Archer, E Souil, AT nh-Xuan, et al. (1998) Molecular identification of the role of voltage-gated K+ channels, Kv1.5 and Kv2.1, in hypoxic pulmonary vasoconstriction and control of resting membrane potential in rat pulmonary artery myocytes. J Clin Invest 101 2319
378. L Perchenet, L Hilfiger, J Mizrahi, et al. (2001) Effects of anorexinogen agents on cloned voltage-gated K(+) channel hKv1.5. J Pharmacol Exp Ther 298 1108
379. EK Weir, HL Reeve, G Johnson, et al. (1998) A role for potassium channels in smooth muscle cells and platelets in the etiology of primary pulmonary hypertension. Chest 114 200S
380. ED Michelakis, MS McMurtry, XC Wu, et al. (2002) Dichloroacetate, a metabolic modulator, prevents and reverses chronic hypoxic pulmonary hypertension in rats: role of increased expression and activity of voltage-gated potassium channels. Circulation 105 244
381. MS McMurtry, S Bonnet, X Wu, et al. (2004) Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis. Circ Res 95 830
382. K Sato, S Webb, A Tucker, et al. (1992) Factors influencing the idiopathic development of pulmonary hypertension in the fawn hooded rat. Am Rev Respir Dis 145 793
383. TD Le Cras, DH Kim, NE Markham, et al. (2000) Early abnormalities of pulmonary vascular development in the Fawn-Hooded rat raised at Denver's altitude. Am J Physiol Lung Cell Mol Physiol 279 L283
384. LE Huang, Z Arany, DM Livingston, et al. (1996) Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. J Biol Chem 271 32253
385. PW Stacpoole, NV Nagaraja and AD Hutson (2003) Efficacy of dichloroacetate as a lactate-lowering drug. J Clin Pharmacol 43 683
386. RT Schermuly, E Dony, HA Ghofrani, et al. (2005) Reversal of experimental pulmonary hypertension by PDGF inhibition. J Clin Invest 115 2811
387. V Balasubramaniam, TD Le Cras, DD Ivy, et al. (2003) Role of platelet-derived growth factor in vascular remodeling during pulmonary hypertension in the ovine fetus. Am J Physiol Lung Cell Mol Physiol 284 L826
388. HA Ghofrani, W Seeger and F Grimminger (2005) Imatinib for the treatment of pulmonary arterial hypertension. N Engl J Med 353 1412
389. KC Patterson, A Weissmann, T Ahmadi, et al. (2006) Imatinib mesylate in the treatment of refractory idiopathic pulmonary arterial hypertension. Ann Intern Med 145 152
390. R Souza, O Sitbon, F Parent, et al. (2006) Long term imatinib treatment in pulmonary arterial hypertension. Thorax 61 736
391. S Zhang, I Fantozzi, DD Tigno, et al. (2003) Bone morphogenetic proteins induce apoptosis in human pulmonary vascular smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 285 L740
392. NW Morrell, X Yang, PD Upton, et al. (2001) Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-beta(1) and bone morphogenetic proteins. Circulation 104 790
393. KB Lane, RD Machado, MW Pauciulo, et al. (2000) Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. The International PPH Consortium. Nat Genet 26 81
394. DC Altieri (2003) Validating survivin as a cancer therapeutic target. Nat Rev Cancer 3 46
395. OP Blanc-Brude, J Yu, H Simosa, et al. (2002) Inhibitor of apoptosis protein survivin regulates vascular injury. Nat Med 8 987
396. JH Newman, BL Fanburg, SL Archer, et al. (2004) Pulmonary arterial hypertension: future directions: report of a National Heart, Lung and Blood Institute/Office of Rare Diseases workshop. Circulation 109 2947
397. U Laufs, D Marra, K Node, et al. (1999) 3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors attenuate vascular smooth muscle proliferation by preventing rho GTPase-induced down-regulation of p27(Kip1). J Biol Chem 274 21926
398. C Indolfi, A Cioppa, E Stabile, et al. (2000) Effects of hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin on smooth muscle cell proliferation in vitro and neointimal formation in vivo after vascular injury. J Am Coll Cardiol 35 214
399. T Nishimura, LT Vaszar, JL Faul, et al. (2003) Simvastatin rescues rats from fatal pulmonary hypertension by inducing apoptosis of neointimal smooth muscle cells. Circulation 108 1640
400. RE Girgis, D Li, X Zhan, et al. (2003) Attenuation of chronic hypoxic pulmonary hypertension by simvastatin. Am J Physiol Heart Circ Physiol 285 H938
401. U Laufs, VL Fata and JK Liao (1997) Inhibition of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase blocks hypoxia-mediated down-regulation of endothelial nitric oxide synthase. J Biol Chem 272 31725
402. S Dimmeler, A Aicher, M Vasa, et al. (2001) HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 108 391
403. M Takemoto, J Sun, J Hiroki, et al. (2002) Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase. Circulation 106 57
404. E Gurbanov and X Shiliang (2006) The key role of apoptosis in the pathogenesis and treatment of pulmonary hypertension. Eur J Cardiothorac Surg 30 499
405. K Abe, H Shimokawa, K Morikawa, et al. (2004) Long-term treatment with a Rho-kinase inhibitor improves monocrotaline-induced fatal pulmonary hypertension in rats. Circ Res 94 385
406. KA Fagan, M Oka, NR Bauer, et al. (2004) Attenuation of acute hypoxic pulmonary vasoconstriction and hypoxic pulmonary hypertension in mice by inhibition of Rho-kinase. Am J Physiol Lung Cell Mol Physiol 287 L656
407. T Nagaoka, KA Fagan, SA Gebb, et al. (2005) Inhaled Rho kinase inhibitors are potent and selective vasodilators in rat pulmonary hypertension. Am J Respir Crit Care Med 171 494
408. N Nagaya, K Kangawa, M Kanda, et al. (2003) Hybrid cell-gene therapy for pulmonary hypertension based on phagocytosing action of endothelial progenitor cells. Circulation 108 889
409. SR Baber, W Deng, RG Master, et al. (2007) Intratracheal mesenchymal stem cell administration attenuates monocrotaline-induced pulmonary hypertension and endothelial dysfunction. Am J Physiol Heart Circ Physiol 292 H1120
410. S Kanki-Horimoto, H Horimoto, S Mieno, et al. (2006) Implantation of mesenchymal stem cells overexpressing endothelial nitric oxide synthase improves right ventricular impairments caused by pulmonary hypertension. Circulation 114 I181
411. BO Okoye, PD Losty, DA Lloyd, et al. (1998) Effect of prenatal glucocorticoids on pulmonary vascular muscularisation in nitrofen-induced congenital diaphragmatic hernia. J Pediatr Surg 33 76
412. T Yamataka and P Puri (1997) Active collagen synthesis by pulmonary arteries in pulmonary hypertension complicated by congenital diaphragmatic hernia. J Pediatr Surg 32 682
413. M Sakai, K Unemoto, V Solari, et al. (2004) Decreased expression of voltage-gated K+ channels in pulmonary artery smooth muscle cells in nitrofen-induced congenital diaphragmatic hernia in rats. Pediatr Surg Int 20 192
414. DH Anderson (1941) Incidence of congenital diaphragmatic hernia in the young of rats bred on a diet deficient in Vitamin A. Am J Dis Child 62 888
415. DH Anderson (1949) Effect of diet during pregnancy upon the incidence of congenital hereditary diaphragmatic hernia in the rat. Am J Path 25 163
416. JG Wilson, CB Roth and J Warkany (1953) An analysis of the syndrome of malformations induced by maternal vitamin A deficiency. Effects of restoration of vitamin A at various times during gestation. Am J Anat 92 189
417. C Mendelsohn, D Lohnes, D Decimo, et al. (1994) Function of the retinoic acid receptors (RARs) during development (II). Multiple abnormalities at various stages of organogenesis in RAR double mutants. Development 120 2749
418. D Lohnes, M Mark, C Mendelsohn, et al. (1995) Developmental roles of the retinoic acid receptors. J Steroid Biochem Mol Biol 53 475
419. AM Ambrose, PS Larson, JF Borzelleca, et al. (1971) Toxicologic studies on 2,4-dichlorophenyl-p-nitrophenyl ether. Toxicol Appl Pharmacol 19 263
420. RD Costlow and JM Manson (1981) The heart and diaphragm: target organs in the neonatal death induced by nitrofen (2,4-dichlorophenyl-p-nitrophenyl ether). Toxicology 20 209
421. D Kluth, R Kangah, P Reich, et al. (1990) Nitrofen-induced diaphragmatic hernias in rats: an animal model. J Pediatr Surg 25 850
422. L Migliazza, H Xia, JA ez-Pardo, et al. (1999) Skeletal malformations associated with congenital diaphragmatic hernia: experimental and human studies. J Pediatr Surg 34 1624
423. B Thebaud, D Tibboel, C Rambaud, et al. (1999) Vitamin A decreases the incidence and severity of nitrofen-induced congenital diaphragmatic hernia in rats. Am J Physiol 277 L423
424. J Mey, RP Babiuk, R Clugston, et al. (2003) Retinal dehydrogenase-2 is inhibited by compounds that induce congenital diaphragmatic hernias in rodents. Am J Pathol 162 673
425. B Thebaud, AM Barlier-Mur, B Chailley-Heu, et al. (2001) Restoring effects of vitamin A on surfactant synthesis in nitrofen-induced congenital diaphragmatic hernia in rats. Am J Respir Crit Care Med 164 1083
426. D Major, M Cadenas, L Fournier, et al. (1998) Retinol status of newborn infants with congenital diaphragmatic hernia. Pediatr Surg Int 13 547
427. JJ Greer, RP Babiuk and B Thebaud (2003) Etiology of congenital diaphragmatic hernia: the retinoid hypothesis. Pediatr Res 53 726
428. DT Wilcox, PL Glick, HL Karamanoukian, et al. (1997) Contributions by individual lungs to the surfactant status in congenital diaphragmatic hernia. Pediatr Res 41 686
429. MR Mysore, LR Margraf, MA Jaramillo, et al. (1998) Surfactant protein A is decreased in a rat model of congenital diaphragmatic hernia. Am J Respir Crit Care Med 157 654
430. K Asabe, K Tsuji, N Handa, et al. (1997) Immunohistochemical distribution of surfactant apoprotein-A in congenital diaphragmatic hernia. J Pediatr Surg 32 667
431. A Lotze, GR Knight, KD Anderson, et al. (1994) Surfactant (beractant) therapy for infants with congenital diaphragmatic hernia on ECMO: evidence of persistent surfactant deficiency. J Pediatr Surg 29 407
432. SJ O'Toole, HL Karamanoukian, FC Morin III, et al. (1996) Surfactant decreases pulmonary vascular resistance and increases pulmonary blood flow in the fetal lamb model of congenital diaphragmatic hernia. J Pediatr Surg 31 507
433. JJ Coalson (1999) Pathology of chronic lung disease of early infancy. RD Bland, JJ Coalson,(Eds) Chronic lung disease in early infancy Informa Healthcare 85-124
434. JJ Coalson, VT Winter, T Siler-Khodr, et al. (1999) Neonatal chronic lung disease in extremely immature baboons. Am J Respir Crit Care Med 160 1333
435. AH Jobe and E Bancalari (2001) Bronchopulmonary dysplasia. Am J Respir Crit Care Med 163 1723
436. AJ Jobe (1999) The new BPD: an arrest of lung development. Pediatr Res 46 641
437. DC McCurnin, RA Pierce, LY Chang, et al. (2005) Inhaled NO improves early pulmonary function and modifies lung growth and elastin deposition in a baboon model of neonatal chronic lung disease. Am J Physiol Lung Cell Mol Physiol 288 L450
438. RD Bland, KH Albertine, DP Carlton, et al. (2005) Inhaled nitric oxide effects on lung structure and function in chronically ventilated preterm lambs. Am J Respir Crit Care Med 172 899
439. YJ Lin, NE Markham, V Balasubramaniam, et al. (2005) Inhaled nitric oxide enhances distal lung growth after exposure to hyperoxia in neonatal rats. Pediatr Res 58 22
440. V Balasubramaniam, AM Maxey, DB Morgan, et al. (2006) Inhaled NO restores lung structure in eNOS-deficient mice recovering from neonatal hypoxia. Am J Physiol Lung Cell Mol Physiol 291 L119
441. JR Tang, NE Markham, YJ Lin, et al. (2004) Inhaled nitric oxide attenuates pulmonary hypertension and improves lung growth in infant rats after neonatal treatment with a VEGF receptor inhibitor. Am J Physiol Lung Cell Mol Physiol 287 L344
442. WM Maniscalco, RH Watkins, JN Finkelstein, et al. (1995) Vascular endothelial growth factor mRNA increases in alveolar epithelial cells during recovery from oxygen injury. Am J Respir Cell Mol Biol 13 377
443. A Papapetropoulos, G Garcia-Cardena, JA Madri, et al. (1997) Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest 100 3131
444. J Kroll and J Waltenberger (1999) A novel function of VEGF receptor-2 (KDR): rapid release of nitric oxide in response to VEGF-A stimulation in endothelial cells. Biochem Biophys Res Commun 265 636
445. TD Le Cras, NE Markham, RM Tuder, et al. (2002) Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure. Am J Physiol Lung Cell Mol Physiol 283 L555
446. AJ Bhatt, GS Pryhuber, H Huyck, et al. (2001) Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. Am J Respir Crit Care Med 164 1971
447. WM Maniscalco, RH Watkins, GS Pryhuber, et al. (2002) Angiogenic factors and alveolar vasculature: development and alterations by injury in very premature baboons. Am J Physiol Lung Cell Mol Physiol 282 L811
448. JC Fouron, JC Le Guennec, D Villemant, et al. (1980) Value of echocardiography in assessing the outcome of bronchopulmonary dysplasia of the newborn. Pediatrics 65 529
449. SH Abman, FJ Accurso and CM Bowman (1984) Unsuspected cardiopulmonary abnormalities complicating bronchopulmonary dysplasia. Arch Dis Child 59 966
450. N Nagaya, T Nishikimi, M Uematsu, et al. (2000) Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. Circulation 102 865